⬆ 2 Healthcare & Biotech Stocks Up Over 50% Past 2 Weeks & Up Today
#SymbolCompanyCategory% Price Change Past 10 DaysPerformance vs. Industry1RMSLREMSleep Holdings Inc.Healthcare+384%+336%2TVMD24/7 Kid Doc Inc.Healthcare+275%+492%
⬆ 2 Healthcare & Biotech Stocks Up Over 50% Past 2 Weeks & Up Today
2 Healthcare & Biotech Stocks Up Over 50% Past 2 Weeks & Up TodayPowered by politicsandmyportfolio.comBelow is a list of[...]
⬆ 2 Healthcare & Biotech Stocks Up Over 50% Past 2 Weeks & Up Today
2 Consumer Stocks Up Over 67% Past 2 Weeks & Up TodayBelow is a list of 2 Healthcare & Biotech[...]
⬆ 2 Healthcare & Biotech Stocks Up Over 47% Past 2 Weeks & Up Today
2 Healthcare & Biotech Stocks Up Over 47% Past 2 Weeks & Up TodayPowered by politicsandmyportfolio.comBelow is a list of[...]
⬆ 2 Healthcare & Biotech Stocks Up Over 67% Past 2 Weeks & Up Today
2 Healthcare & Biotech Stocks Up Over 67% Past 2 Weeks & Up TodayPowered by politicsandmyportfolio.comBelow is a list of 2[...]
⬆ 2 Healthcare & Biotech Stocks Up Over 84% Past 2 Weeks & Up Today
2 Healthcare & Biotech Stocks Up Over 84% Past 2 Weeks & Up TodayPowered by politicsandmyportfolio.comBelow is a list of 2[...]
Merck ends development of Covid drug it acquired from OncoImmune Merck announced Thursday it will end the development of its experimental drug for patients hospitalized with severe Covid-19.
India's second wave of Covid shows no signs of slowing as country reports over 200,000 new cases Since the beginning of April, India has reported more than 1.9 million new cases and over 10,600 deaths, per CNBC's calculations of health ministry data.
Maldives to offer holidaymakers vaccines on arrival in a push to revive tourism Maldives is set to offer visitors vaccinations on arrival as part of its three-pronged initiative aimed at reviving the country's hard hit tourism sector.
Myth or reality? Health experts weigh in on whether 'herd immunity' is possible Some experts say it is achievable, though difficult — but others are warning that herd immunity may not be possible when it comes to Covid-19.
Surgeon says pausing J&J vaccine for younger populations makes sense, but could be lifted for older age groups Dr. Atul Gawande explains why he “thinks there is something distinct going on here” when it comes to blood clotting and J&J's single-dose Covid-19 vaccine.